Business Practice

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

You’ve got the lab, the tools, and the equipment; now, you need integration and orchestration for a seamless workflow.

As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Donald Trump threatens “major tariff” on pharmaceuticals.

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.